Share this article
Share this article
ResearchAndMarkets.com s offering.
This report focuses on diagnostics. The World Market for Biomarkers estimates the world markets for biomarkers and biomarker tests from 2015 to 2024, with 2020 as the base year, providing global biomarker market forecasts for the total biomarker market.
Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications.
The "The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, Auto-Immune and Others)" report has been added to ResearchAndMarkets.com's offering.
COVID-19 Diagnostics Market Size Worth USD 8.04 Billion at 2.7% CAGR; Pharmaceutical Giants Such as Abbott and Roche to Pump More Funds for R&D Activities: Fortune Business Insights™ Key Prominent Players Covered in the COVID-19 Diagnostics Market Research Report Are PerkinElmer Inc. , Quest Diagnostics Incorporated , Quidel Corporation , Siemens Healthcare GmbH, Abbott Thermo Fisher Scientific Inc. , bioMérieux SA , F. Hoffmann-La Roche Ltd , Danaher Corporation
March 01, 2021 06:57 ET | Source: Fortune Business Insights Fortune Business Insights
Pune, India, March 01, 2021 (GLOBE NEWSWIRE) The global
COVID-19 diagnostics market size is projected to reach USD 8.04 billion by 2027, exhibiting a CAGR of 2.7% during the forecast period. Uncontrolled spread of the coronavirus worldwide will be the major factor propelling the growth of this market, shares Fortune Business Insights™ in its report, titled “COVID-19 Diagnostics